Literature DB >> 27239603

Post-thyroidectomy iatrogenic Horner's syndrome with heterochromia.

Mahmut Oğuz Ulusoy1, Sertaç Argun Kıvanç2, Mehmet Atakan3, Hüseyin Mayalı4.   

Abstract

PURPOSE: To present a case of iatrogenic Horner's syndrome seen together with the heterochromia in the post-thyroidectomy period.
METHODS: A 23-year-old female patient was admitted to our clinic with complaints of low vision in the eye and difference in eye color that developed over the past two years. In the left eye, myosis and minimal ptosis (∼1 mm) was detected, and the color of the iris was lighter than the right eye.
RESULTS: The pre-diagnosis of left iatrogenic Horner's syndrome was finalized after 0.5% topical apraclonidine test.
CONCLUSION: Heterochromia can be observed in iatrogenic Horner's syndrome.

Entities:  

Keywords:  Anisocoria; Heterochromia iridis; Horner's syndrome; Thyroidectomy

Year:  2016        PMID: 27239603      PMCID: PMC4881223          DOI: 10.1016/j.joco.2016.02.004

Source DB:  PubMed          Journal:  J Curr Ophthalmol        ISSN: 2452-2325


Introduction

Horner's syndrome is a result of damage to the oculosympathetic nerve fibers. The symptoms vary depending on whether it is preganglionic or postganglionic. While anhidrosis is seen in preganglionic cases, heterochromia is considered a part of congenital Horner's syndrome. In this particular case, we investigated acquired Horner's syndrome with heterochromia that developed as a result of total thyroidectomy.

Case report

A 23-year-old female patient was admitted to our clinic with complaints of low vision and difference in eye color growing over the past two to three years. The patient stated that she suffered from a total thyroidectomy 4 years earlier. In the ophthalmologic examination of the patient, the visual acuities were 12/20 in the right eye and 20/20 in the left eye. The visual acuity difference of the patient was linked to anisometropic amblyopia (OD + 4.00 + 4.50 × 110 OS + 1.25 × 70). Anisocoria was detected in the patient with myosis in the left eye (Fig. 1). The light reflexes on both sides of the patient were directly and indirectly normal. The patient had heterochromia with light iris color in the left eye. Ptosis (∼1 mm) was detected in the left eye. Fundus examination was normal in both eye. Intraocular pressures in the right and left were 12 and 14 mmHg, respectively. As a result of the existing complaints, background, and examinations findings of the patient, she was given the provisional diagnosis of Horner's syndrome. In an attempt to finalize our diagnosis, we decided to test by the 0.5% Apraclonidine drop (Iopidine; Alcon, Fort Worth, Texas). After 0.5% Apraclonidine drops in both eyes, the examination was repeated in the 30th and 60th minutes. While explicit mydriasis in the left eye and mild retraction in the upper eyelid were detected, no mydriasis was found in the right eye (Fig. 2).
Fig. 1

Pupil size before apraclonidine instillation.

Fig. 2

Pupil size 60 min after apraclonidine instillation.

Discussion

Oculosympathetic innervation is a three-neuron pathway starting in the central nervous system and finalizing in the eye. Interruption of this innervation causes mild ptosis on the affected upper eyelid, anhidrosis and myosis. Also, heterochromia occurs in congenital cases. While congenital cases may be linked to idiopathic or birth trauma, the tumoral infiltration which is common in the adult period may occur as a result of surgery and trauma. Moreover, Horner's syndrome may occur secondary to benign thyroid lesions. In our patient, Horner's syndrome was secondary to the thyroid surgery. Because access to the patient's surgery records was not available, the nature of primary lesion (malignant versus benign) was unknown. Due to the fact that the patient did not receive any other treatment except surgery and her screening was interrupted, we believe that it was benign. What differentiates this particular case from other iatrogenic Horner is the availability of heterochromia just like in congenital cases. To best of our knowledge, few cases were reported to have acquired Horner's syndrome with heterochromia in the literature.4, 5, 6 With the exception of Diesenhouse's and Byrne's report,7, 8 most of these cases were acquired Horner's syndrome which developed in childhood. The researchers investigating congenital Horner's syndrome believe that the interruption of postganglionic pathway caused neurotropic diagenesis in the iris melanocytes. Moreover, the melanocytes in the stroma and sympathetic nerve endings were electron-microscopically defined and it was reported that iris hyperpigmentation was due to the melanocyte recruitment from the neural crest. It was reported that as a result of showing heterochromia in adult Horner's syndrome, this particular situation occurred due to the damage to the cells rather than the loss of the cells as a result of denervation. Even though Horner's syndrome can be clinically diagnosed, it should be confirmed by some pharmacologic tests in order to be able to differentiate them from the other anisocoria and ptosis causes, especially in adults.10, 11 While cocaine and apraclonidine are diagnostic in these tests, hydroxyamphetamine test can be used in differentiating pre-post ganglionic cases. Apraclonidine, which is alpha adrenergic agonist, finalizes the diagnosis by actualizing the mydriasis in eyes in which Horner's syndrome-related denervation hypersensitivity has developed. Since apraclonidine has recently become readily available and is difficult to differentiate with respect to sensitivity and specificity from cocaine, it has been used late more than before.12, 13 As we only had apraclonidine 0.5% available, we did this test and confirmed our Horner's syndrome diagnosis. In conclusion, the development of Horner's syndrome as a result of neck surgery and especially thyroid surgery has been reported many times in the literature and is a well-known case. The present case shows that iris heterochromia may develop in iatrogenic Horner's syndrome in adults as well.
  12 in total

1.  Hypochromia iridis in acquired Horner's syndrome.

Authors:  P Byrne; C Clough
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-05       Impact factor: 10.154

2.  Apraclonidine in the diagnosis of Horner's syndrome.

Authors:  A A Moodley; R B Spooner
Journal:  S Afr Med J       Date:  2007-07

3.  Pharmacological reversal of ptosis in a patient with acquired Horner's syndrome and heterochromia.

Authors:  C F Parsa; N D George; C S Hoyt; N D George
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

4.  Topographic analysis of Horner's syndrome.

Authors:  P G Smith; T J Dyches; R M Burde
Journal:  Otolaryngol Head Neck Surg       Date:  1986-04       Impact factor: 3.497

5.  The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis.

Authors:  F Koc; S Kavuncu; T Kansu; G Acaroglu; E Firat
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

6.  [Iris heterochromia in acquired Horner's syndrome].

Authors:  J Beynat; P Soichot; S Bidot; B Dugas; C Creuzot-Garcher; A Bron
Journal:  J Fr Ophtalmol       Date:  2007-09       Impact factor: 0.818

7.  Acquired heterochromia with horner syndrome in two adults.

Authors:  M C Diesenhouse; D A Palay; N J Newman; K To; D M Albert
Journal:  Ophthalmology       Date:  1992-12       Impact factor: 12.079

8.  Congenital Horner's syndrome.

Authors:  J M Weinstein; T J Zweifel; H S Thompson
Journal:  Arch Ophthalmol       Date:  1980-06

9.  [Usefulness of apraclonidine in the diagnosis of Horner syndrome].

Authors:  M A Pérez-Iñigo; I González; F J Fernández; S Díaz; C Ferrer; E Alias; F M Honrubia
Journal:  Arch Soc Esp Oftalmol       Date:  2009-02

10.  Postthyroidectomy Horner's Syndrome.

Authors:  Ramon Vilallonga; José Manuel Fort; Alejandro Mazarro; Oscar Gonzalez; Enric Caubet; Giancarlo Romero; Manel Armengol
Journal:  Case Rep Med       Date:  2012-10-21
View more
  1 in total

1.  Reversal of Iris Heterochromia in Adult-Onset Acquired Horner Syndrome.

Authors:  Tanyatuth Padungkiatsagul; Lakshmi Leishangthem; Heather E Moss
Journal:  J Neuroophthalmol       Date:  2021-06-01       Impact factor: 4.415

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.